135 related articles for article (PubMed ID: 3879757)
1. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
Sinha R; Gupta SC; Naithani YP
Indian J Cancer; 1985 Mar; 22(1):8-16. PubMed ID: 3879757
[No Abstract] [Full Text] [Related]
2. Immune defects in patients with head and neck cancer.
Wustrow TP; Issing WJ
Anticancer Res; 1993; 13(6B):2507-19. PubMed ID: 8135491
[TBL] [Abstract][Full Text] [Related]
3. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
Stefano S; Kerman R; Abbate J
AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
[TBL] [Abstract][Full Text] [Related]
4. Advances in the immunology of head and neck cancer.
Katz AE
Otolaryngol Clin North Am; 1980; 13(3):431-6. PubMed ID: 6777739
[TBL] [Abstract][Full Text] [Related]
5. Changes in cellular immunity in patients with head and neck cancer undergoing radiotherapy.
Yaneva M; Grigorov L; Dimitrova M; Videva V; Kovacheva B; Tosheva K; Andreeva S
Folia Med (Plovdiv); 1985; 27(1):22-6. PubMed ID: 3937799
[No Abstract] [Full Text] [Related]
6. [Controlled study of unspecific cellular immunity in cancer patients].
Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
[TBL] [Abstract][Full Text] [Related]
7. Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer.
Pierri I; Cordone G; Rogna S; Pende D; Garaventa G; Barabino A; Indiveri F
Cancer Detect Prev; 1984; 7(2):73-8. PubMed ID: 6231991
[TBL] [Abstract][Full Text] [Related]
8. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
Rabin BS; Johnson J; Claassen D
Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
[TBL] [Abstract][Full Text] [Related]
9. [Cellular immune reactivity in Tumor patients: peripheral blood T-lymphocytes (author's transl)].
Sesterhenn K; Krueger GR; Uhlmann C
Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):807-14. PubMed ID: 144215
[No Abstract] [Full Text] [Related]
10. Correlation of immune reactivity and clinical status in cancer.
Chretien PB; Catalona WJ; Twomey PL; Sample WF
Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
[No Abstract] [Full Text] [Related]
11. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
[TBL] [Abstract][Full Text] [Related]
12. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
13. [Delayed skin reaction in head and neck cancer patient].
Nagata M
Nihon Jibiinkoka Gakkai Kaiho; 1983 Dec; 86(12):1478-86. PubMed ID: 6609230
[No Abstract] [Full Text] [Related]
14. [Features of immunologic and virusologic indicators in oncology patients].
Sevost'ianova NV; Isaeva TM; Urazova LN
Vopr Onkol; 2001; 47(4):446-8. PubMed ID: 11710288
[TBL] [Abstract][Full Text] [Related]
15. [Cell immunity factors in patients with lung cancer treated by the split-course schedule method].
Zhakov IG; Rybakov NI; Danilova TS; Pankina VKh
Vopr Onkol; 1980; 26(4):75-9. PubMed ID: 6966446
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunity in patients with head-and-neck cancer.
Skinner MD; Kashima HK; Braverman G; Kalinowski B
Ear Nose Throat J; 1979 Feb; 58(2):98-100. PubMed ID: 436684
[No Abstract] [Full Text] [Related]
17. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
18. [Studies of immunological status and prognosis on patients with head and neck cancer--with particular emphasis on influence of cancer treatments].
Sakuda M; Sayama K; Nakazawa M; Nukata J; Sugahara T; Amino K; Tsujino M
Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2376-86. PubMed ID: 3449586
[No Abstract] [Full Text] [Related]
19. [Critical study of immunological assessment in cancer patients (author's transl)].
Bagarry-Liegey D; Meyer G
Bull Cancer; 1981; 68(5):403-16. PubMed ID: 7332788
[TBL] [Abstract][Full Text] [Related]
20. Prognostic variables in head and neck cancer. Tumor site, stage, nodal status, differentiation, and immune status.
Davis RK
Otolaryngol Clin North Am; 1985 Aug; 18(3):411-9. PubMed ID: 4047665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
